Drug Search Results
More Filters [+]

DB-1202

Alternative Names: DB-1202, DB 1202, DB1202
Latest Update: 2023-03-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Antibody

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: DualityBio
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for DB-1202

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Thyroid Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DB-1202-O-1001

P2

Not yet recruiting

Thyroid Cancer

2024-02-28

Recent News Events

Date

Type

Title